In the News

February 2025

Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA

February 2024

LifeLink® Tissue Bank and Britecyte® Join Forces to Pioneer Advancements in Adipose Tissue Technology

June 2022

Britecyte’s Research Project “A Mesenchymal Stem Cell Containing Matrix for Nonalcoholic Steatohepatitis (NASH)” was awarded a $270,000 Commercialization Program Grant from the Maryland Stem Cell Research Fund (MSCRF)

View Article